204 related articles for article (PubMed ID: 33972684)
1. MALAT1 modulated FOXP3 ubiquitination then affected GINS1 transcription and drived NSCLC proliferation.
Li M; Shi M; Hu C; Chen B; Li S
Oncogene; 2021 Jun; 40(22):3870-3884. PubMed ID: 33972684
[TBL] [Abstract][Full Text] [Related]
2. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC).
Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM
Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
4. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
6. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
Liu M; Sun W; Liu Y; Dong X
Oncol Rep; 2016 Sep; 36(3):1679-85. PubMed ID: 27431200
[TBL] [Abstract][Full Text] [Related]
7. MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis.
Fan H; Yuan J; Li Y; Jia Y; Li J; Wang X; Li X
Cell Death Dis; 2021 Jan; 12(1):128. PubMed ID: 33500406
[TBL] [Abstract][Full Text] [Related]
8. Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
Feng J; Xu L; Ni S; Gu J; Zhu H; Wang H; Zhang S; Zhang W; Huang J
Oncotarget; 2014 Oct; 5(20):9689-702. PubMed ID: 25356753
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer.
Shi X; Ma C; Zhu Q; Yuan D; Sun M; Gu X; Wu G; Lv T; Song Y
Oncotarget; 2016 May; 7(18):25558-75. PubMed ID: 27027352
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
11. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
Wei S; Wang K; Huang X; Zhao Z; Zhao Z
Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
Li S; Mei Z; Hu HB; Zhang X
J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
[TBL] [Abstract][Full Text] [Related]
15. FOXP3 activated-LINC01232 accelerates the stemness of non-small cell lung carcinoma by activating TGF-β signaling pathway and recruiting IGF2BP2 to stabilize TGFBR1.
Zhu L; Liu Y; Tang H; Wang P
Exp Cell Res; 2022 Apr; 413(2):113024. PubMed ID: 35026283
[TBL] [Abstract][Full Text] [Related]
16. Salidroside regulates tumor microenvironment of non-small cell lung cancer via Hsp70/Stub1/Foxp3 pathway in Tregs.
Wen Z; Liu T; Zhang Y; Yue Q; Meng H; He Y; Yang Y; Li M; Zheng J; Lin W
BMC Cancer; 2023 Aug; 23(1):717. PubMed ID: 37528345
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
Li Q; Jiang B; Qi Y; Zhang H; Ma H
Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
[TBL] [Abstract][Full Text] [Related]
18. Regulation of MALAT1 expression by TDP43 controls the migration and invasion of non-small cell lung cancer cells in vitro.
Guo F; Jiao F; Song Z; Li S; Liu B; Yang H; Zhou Q; Li Z
Biochem Biophys Res Commun; 2015 Sep; 465(2):293-8. PubMed ID: 26265046
[TBL] [Abstract][Full Text] [Related]
19. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
[TBL] [Abstract][Full Text] [Related]
20. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]